Should You Buy NuScale Power While It's Below $20?

NuScale Power is positioned around a potential $10 trillion nuclear energy market opportunity tied to small modular reactors, especially for AI data centers and other on-site power users. However, it still has no firm commercial sale, no meaningful SMR revenue, and the technology remains unproven despite NRC design approval. The stock is down over 75% from its October 2025 highs and now trades below $13, reflecting a high-risk, high-upside setup.

Analysis

The market is pricing SMR as a binary option on first-mover credibility, not on near-term cash flow. That matters because the first commercial site is less about unit economics than about who absorbs integration risk: engineering firms, EPC contractors, fuel suppliers, and offtake counterparties will demand de-risked contracts before capital clears. If SMR becomes a repeatable template, the beneficiaries are likely to be the picks-and-shovels layer first, not the developer itself; the value capture may shift toward balance-sheet-heavy industrials that can finance, build, and own the assets.

The second-order effect is on power procurement behavior in data centers and industrial parks. Even a modest delay in grid interconnection can push hyperscalers to sign long-duration behind-the-meter PPAs with alternative generation, which would support not only nuclear but also gas peakers, grid equipment, and transmission bottlenecks as stopgap solutions. That creates a near-term wedge where the biggest public-market beneficiaries may be equipment vendors and utilities with existing land, permits, and operating capability rather than pure-play SMR developers.

The key risk is timing: this remains a years-not-months story, and the market is unlikely to pay for optionality indefinitely if there is no binding commercial contract. A credible first sale or government-backed anchor tenant could re-rate the name sharply, but another project cancellation or capex surprise would likely compress the multiple further because it would validate the view that technical approval is not the same as bankability. Consensus may be underestimating how little equity value exists before the first financed plant is proven.

Contrarian view: the setup is not necessarily bullish for SMR equity even if the nuclear thesis is right. The cleaner way to express the theme is to own the infrastructure enablers that benefit from any accelerated siting and grid-stress narrative, while treating SMR as a high-volatility call option whose execution risk can remain unresolved for 12-24 months.

Key Decisions for Investors

• Avoid initiating a standalone long in SMR ahead of a firm, financed first-order contract; use it only as a small optionality position because downside remains tied to another execution delay over the next 12-24 months.
• Pair trade: long infrastructure beneficiaries (ETN or PWR) versus short SMR for 6-12 months. If AI-driven load growth forces alternative generation and interconnect buildout, the enablers monetize first while SMR bears project-risk dilution.
• For higher-risk accounts, buy 6-18 month call spreads in SMR only on a confirmed catalyst such as a signed utility or data-center PPA. Risk/reward improves only when commercial validation replaces narrative.
• Use BAC as a monitoring signal, not a trade: if large-bank financing rhetoric turns into project finance commitments, expect a sharp re-rating in SMR and adjacent nuclear names within weeks, not quarters.
• If the first contract is announced, consider a tactical momentum long in SMR with a tight trailing stop; the upside is a fast sentiment squeeze, but the position should be reduced on any sign of capex escalation or delayed FID.